Derivation and validation of a renal risk score for people with type 2 diabetes

Diabetes Care

Volumn 36, Issue 10, 2013, Pages 3113-3120

  Elley, C Raina ^a   Robinson, Tom ^a   Moyes, Simon A ^a   Kenealy, Tim ^a   Collins, John ^b   Robinson, Elizabeth ^a   Orr Walker, Brandon ^c   Drury, Paul L ^b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b AUCKLAND DISTRICT HEALTH BOARD   (New Zealand)

^c Division of Medicine Emergency and Integrated Care   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; HEMOGLOBIN A1C;

ADULT; ALBUMINURIA; ARTICLE; CARDIOVASCULAR DISEASE; CREATININE BLOOD LEVEL; DEATH; DISEASE DURATION; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NEW ZEALAND; NON INSULIN DEPENDENT DIABETES MELLITUS; PERITONEAL DIALYSIS; PREDICTIVE VALUE; RENAL RISK SCORE; RISK ASSESSMENT; SCORING SYSTEM; SMOKING; SYSTOLIC BLOOD PRESSURE; VALIDITY;

AGED; DIABETES MELLITUS, TYPE 2; FEMALE; GLOMERULAR FILTRATION RATE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; MODELS, THEORETICAL; RISK FACTORS;

EID: 84891878487     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc13-0190     Document Type: Article

References (33)

1. Hippisley-Cox J, Coupland C. Predicting the risk of chronic Kidney Disease in men and women in England and Wales: prospective derivation and external validation of the QKidney Scores. BMC Fam Pract 2010;11:49
2. Atkins RC, Zimmet P. Diabetic kidney disease: act now or pay later. Acta Diabetol 2010;47:1-4
3. BurrowsNR, Li Y,Williams DE. Racial and ethnic differences in trends of end-stage renal disease:United States, 1995 to 2005. Adv Chronic Kidney Dis 2008;15:147-152
4. McClellan WM, Warnock DG, Judd S, et al. Albuminuria and racial disparities in the risk for ESRD. J Am Soc Nephrol 2011;22:1721-1728
5. Ranasinghe P, Perera YS, Makarim MFM, Wijesinghe A, Wanigasuriya K. The costs in provision of haemodialysis in a developing country: a multi-centered study. BMC Nephrol 2011;12:42
6. Sharif A, Baboolal K. Update on dialysis economics in the UK. Perit Dial Int 2011; 31(Suppl. 2):S58-S62
7. Lysaght MJ. Maintenance dialysis population dynamics: current trends and long-termimplications. J AmSoc Nephrol 2002;13(Suppl. 1):S37-S40
8. Hemmingsen B, Lund SS, Gluud C, et al. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus. Cochrane Database Syst Rev 2011;6: CD008143
9. Nosadini R, Velussi M, Brocco E, et al. Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate. Diabetes 2000;49:476-484
10. Strippoli FMG, Bonifati C, Craig ME, Navaneethan SD, Craig JC. Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease. Cochrane Database Syst Rev 2006;4: CD006257
11. Strippoli GFM, Craig ME, Craig JC. Antihypertensive agents for preventing diabetic kidney disease. Cochrane Database Syst Rev 2005;4:CD004136
12. Gansevoort RT, Matsushita K, van der Velde M, et al.; Chronic Kidney Disease Prognosis Consortium. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int 2011;80:93-104
13. Chien KL, Lin HJ, Lee BC, Hsu HC, Lee YT, Chen MF. A prediction model for the risk of incident chronic kidney disease. Am J Med 2010;123:836-846.e2
14. Tangri N, Stevens LA, Griffith J, et al. A predictive model for progression of chronic kidney disease to kidney failure. JAMA 2011;305:1553-1559
15. Keane WF, Zhang Z, Lyle PA, et al.; RENAAL Study Investigators. Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: the RENAAL study. Clin J Am Soc Nephrol 2006;1:761-767
16. Jardine MJ, Hata J, Woodward M, et al.; ADVANCE Collaborative Group. Prediction of kidney-related outcomes in patients with type 2 diabetes. Am J Kidney Dis 2012;60:770-778
17. Elley CR, Kenealy T, Robinson E, Drury PL. Glycated haemoglobin and cardiovascular outcomes in people with Type 2 diabetes: a large prospective cohort study. Diabet Med 2008;25:1295-1301
18. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D; Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999;130:461-470
19. Levey AS, Stevens LA, Schmid CH, et al.; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-612
20. Diabetes Projects Trust Website [Internet], 2012. Available from http://www .dpt.org.nz/. Accessed 7 January 2013
21. Australia and New Zealand Dialysis and Transplant Registry. ANZDATA 34th Annual Report [Internet], 2011. McDonald S, Hurst K, Eds. Available from http://www .anzdata.org.au/anzdata/anzdatareport/ 34threport/2011c00- front%20pages- v1.6.pdf. Accessed 7 January 2013
22. Salmond C, Crampton P, Sutton F. NZDep91: A New Zealand index of deprivation. Aust N Z J Public Health 1998; 22:835-837
23. Therneau T, Grambsch P. Modeling Survival Data: Extending the Cox Model. New York, Springer, 2000
24. Pencina MJ, D'Agostino RB Sr, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 2011;30:11-21
25. Diabetes in New Zealand. Models and Forecasts 1996-2011 [article online], 2002. Available from http://www.health.govt .nz/publication/diabetes-new- zealandmodels- and-forecasts-1996-2011. Accessed 7 January 2013
26. Stevens LA,Greene T, Levey AS. Surrogate end points for clinical trials of kidney disease progression. Clin J AmSoc Nephrol 2006;1:874-884
27. Elley CR, Robinson E, Kenealy T, Bramley D, Drury PL. Derivation and validation of a new cardiovascular risk score for people with type 2 diabetes: the New Zealand diabetes cohort study. Diabetes Care 2010;33:1347-1352
28. Chiu Y-W, Adler S, Budoff M, Takasu J, Ashai J, Mehrotra R. Prevalence and prognostic significance of renal artery calcification in patients with diabetes and proteinuria. Clin J Am Soc Nephrol 2010; 5:2093-2100
29. Cao C, Wan X, Chen Y,WuW. Metabolic factors and microinflammatory state promote kidney injury in type 2 diabetes mellitus patients. Ren Fail 2009;31:470-474
30. Williams ME, Lacson E Jr, Wang W, Lazarus JM, Hakim R. Glycemic control and extended hemodialysis survival in patients with diabetes mellitus: comparative results of traditional and time-dependent Coxmodel analyses.Clin J AmSocNephrol 2010;5:1595-1601
31. O'Seaghdha CM, Perkovic V, Lam TH, et al.; Asia Pacific Cohort Studies Collaboration. Blood pressure is a major risk factor for renal death: an analysis of 560 participants from the Asia-Pacific region. Hypertension 2009;54:509-515
32. Codreanu I, Perico N, Remuzzi G. Dual blockade of the renin-angiotensin system: the ultimate treatment for renal protection? J Am Soc Nephrol 2005;16(Suppl. 1):S34-S38
33. Fioretto P, Solini A. Antihypertensive treatment and multifactorial approach for renal protection in diabetes. J Am Soc Nephrol 2005;16(Suppl. 1):S18-S21